Barclays PLC Portfolio Holdings

Barclays PLC

  • $436 Billion
  • Q2 2025

Barclays PLC has filed its 13F form on August 14, 2025 for Q2 2025 where it was disclosed a total value porftolio of $436 Billion distributed in 12350 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Microsoft Corp with a value of $17.4B, Nvidia Corp with a value of $15.9B, Apple Inc. with a value of $9.34B, Amazon Com Inc with a value of $7.98B, and Tesla, Inc. with a value of $6.51B.

Examining the 13F form we can see an increase of $184B in the current position value, from $252B to 436B.

Barclays PLC is based out at London, X0

Below you can find more details about Barclays PLC portfolio as well as his latest detailed transactions.

Portfolio value $436 Billion
ETFs: $158 Billion
Technology: $99.7 Billion
Consumer Cyclical: $34.9 Billion
Financial Services: $33.3 Billion
Communication Services: $27 Billion
Industrials: $20.8 Billion
Healthcare: $20 Billion
Consumer Defensive: $11.9 Billion
Other: $21.9 Billion

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$2.76B
$5.78 Million 0.0% of portfolio
231,794
Q2 2025 Reduced 37.62%
Confluent Inc
-
$32,000 0.0% of portfolio
-
Q2 2025 Reduced 90.88%
$1.54B
$8.05 Million 0.0% of portfolio
154,518
Q2 2025 Reduced 16.01%
Conmed Corp
-
$1.61 Million 0.0% of portfolio
-
Q2 2025 Reduced 43.03%
$983M
$3.25 Million 0.0% of portfolio
140,215
Q2 2025 Added 45.34%
$556M
$745,000 0.0% of portfolio
32,305
Q2 2025 Added 75.5%
$508M
$771,000 0.0% of portfolio
25,690
Q2 2025 Added 67.13%
$2.2B
$4.34 Million 0.0% of portfolio
326,418
Q2 2025 Added 73.0%
$5.2B
$10.5 Million 0.0% of portfolio
98,904
Q2 2025 Added 54.18%
$176M
$159,000 0.0% of portfolio
16,230
Q2 2025 Added 74.72%
$158M
$310,000 0.0% of portfolio
15,905
Q2 2025 Added 46.81%
Contextlogic Inc
-
$10,000 0.0% of portfolio
-
Q2 2025 Reduced 90.7%
Contineum Therapeutics Inc
-
$7,000 0.0% of portfolio
-
Q2 2025 Reduced 84.37%
$713M
$1,000 0.0% of portfolio
220
Q2 2025 New
$660M
$878,000 0.0% of portfolio
40,864
Q2 2025 Added 37.79%
$3.39B
$242,000 0.0% of portfolio
2,200
Q2 2025 New
Corbus Pharmaceuticals Hldgs
-
$4,000 0.0% of portfolio
-
Q2 2025 Reduced 95.26%
$8.05B
$4.36 Million 0.0% of portfolio
59,362
Q2 2025 Reduced 53.06%
$8.46B
$5.39 Million 0.0% of portfolio
89,324
Q2 2025 Reduced 69.12%
Core Laboratories Inc
-
$1.03 Million 0.0% of portfolio
-
Q2 2025 Added 39.15%
$181M
$266,000 0.0% of portfolio
16,036
Q2 2025 Added 70.18%
Core Natural Resources Inc
-
$7.55 Million 0.0% of portfolio
-
Q2 2025 Added 51.45%
Core Scientific Inc New
-
$12.6 Million 0.0% of portfolio
-
Q2 2025 Added 210.34%
$20.2B
$14 Million 0.0% of portfolio
395,688
Q2 2025 Reduced 3.91%
$228M
$297,000 0.0% of portfolio
10,279
Q2 2025 Added 7,628.57%
$2.43B
$4.37 Million 0.0% of portfolio
207,498
Q2 2025 Added 46.06%
Coreweave Inc
-
$189,000 0.0% of portfolio
-
Q2 2025 New
$498M
$1.79 Million 0.0% of portfolio
145,525
Q2 2025 Added 65.76%
$856M
$872,000 0.0% of portfolio
92,387
Q2 2025 Added 53.88%
$1.42B
$5.91 Million 0.0% of portfolio
57,465
Q2 2025 Added 57.48%
$271M
$1.37 Million 0.0% of portfolio
343,526
Q2 2025 Added 312.74%
Costamare Bulkers Hldgs LTD
-
$146,000 0.0% of portfolio
-
Q2 2025 New
$1.54B
$694,000 0.0% of portfolio
76,246
Q2 2025 Reduced 0.58%
$3.67B
$5.45 Million 0.0% of portfolio
1,172,308
Q2 2025 Added 0.31%
$1.09B
$2.05 Million 0.0% of portfolio
84,060
Q2 2025 Added 57.01%
$53.4B
$1.61 Million 0.0% of portfolio
53,747
Q2 2025 Reduced 87.68%
$1.65B
$11.1 Million 0.0% of portfolio
1,271,642
Q2 2025 Added 8.31%
$4.38B
$4.25 Million 0.0% of portfolio
141,341
Q2 2025 Added 42.89%
$283M
$1.82 Million 0.0% of portfolio
75,327
Q2 2025 Added 8.65%
$170M
$248,000 0.0% of portfolio
10,429
Q2 2025 Added 90.45%
$1.46B
$2.83 Million 0.0% of portfolio
15,110
Q2 2025 Added 53.11%
$1.1B
$4.31 Million 0.0% of portfolio
70,622
Q2 2025 Added 79.16%
Crane Company
-
$7.71 Million 0.0% of portfolio
-
Q2 2025 Reduced 30.47%
$10.1B
$2.58 Million 0.0% of portfolio
47,934
Q2 2025 Added 2.66%
$0
$1.66 Million 0.0% of portfolio
-
Q2 2025 Added 67.5%
$6.52B
$2.62 Million 0.0% of portfolio
5,140
Q2 2025 Added 53.39%
Crescent Biopharma Inc.
-
$4,000 0.0% of portfolio
-
Q2 2025 New
$437M
$367,000 0.0% of portfolio
26,003
Q2 2025 Reduced 84.62%
$407M
$3 Million 0.0% of portfolio
348,442
Q2 2025 Added 56.79%

Summary

  • Portfolio
  • No. of Stocks 12,350
  • Current Value $436 Billion
  • Prior Value $252 Billion
  • Filing
  • Period Q2 2025
  • Filing Date August 14, 2025
  • Form Type 13F-HR/A
  • Activity in Q2 2025
  • New Purchases 0 stocks
  • Additional Purchases 0 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 0 stocks
Track This Portfolio

Track Barclays PLC Portfolio

Follow Barclays PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email